PBM Inertia Won’t Cut It for Employers, Transparency-Rx Panelists Say

Jul 10
Jul 10, 2025

Although high-cost prescription drugs are increasingly busting U.S. employers’ budgets, companies face significant barriers when trying to upend the pharmacy benefits management status quo, panelists said during a recent conference in Washington, D.C.

Still, firms that fail to get a handle on their prescription drug spending could end up facing legal and regulatory risks, speakers suggested during a June 24 panel discussion at the inaugural conference held by Transparency-Rx, a coalition of smaller PBMs that tout transparency business models and are pushing for industry reform.
Read more
© 2025 MMIT

Leslie Small

Leslie has been working in journalism since 2009 and reporting on the health care industry since 2014. She has covered the many ups and downs of the Affordable Care Act exchanges, the failed health insurer mega-mergers, and hundreds of other storylines spanning subjects such as Medicaid managed care, Medicare Advantage, employer-sponsored insurance, and prescription drug coverage. As the managing editor of Health Plan Weekly and Radar on Drug Benefits, she writes and edits for both publications while overseeing a small team of reporters who also focus on the managed care sector. Before joining AIS Health, she was a senior editor for the e-newsletter Fierce Health Payer, and she started her career as a copy editor at multiple local newspapers. She graduated with a dual degree in journalism and political science from Penn State University.